PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24851271-8	2014	At 24 h treatment of hPDLSCs with BzATP it enhanced the release of the pro-inflammatory agents IL8 and CCL20, without influencing cell viability.	BzATP	34-39	C-X-C motif chemokine ligand 8	Homo sapiens	95-98	
19265173-6	2009	Both alpha,beta-meATP and BzATP caused Ca(2+)-dependent binding of phosphorylated p65 (S536) NF-kappaB subunit to the endogenous IL-8 gene promoter in NT-1 cells.	BzATP	26-31	C-X-C motif chemokine ligand 8	Homo sapiens	129-133	
12711624-7	2003	Release of IL-8 was triggered by UDP, ATP, alpha,beta-meATP and BzATP, but not by UTP or ADP.	BzATP	64-69	C-X-C motif chemokine ligand 8	Homo sapiens	11-15	
12711624-10	2003	Release of IL-8 stimulated by BzATP was fully blocked by the P2X(7) blocker KN-62, while release triggered by ATP was only partially inhibited.	BzATP	30-35	C-X-C motif chemokine ligand 8	Homo sapiens	11-15	
19265173-8	2009	Application of alpha,beta-meATP or BzATP at the apical side of polarized human primary nasal epithelial cells sufficed to cause CaMK-dependent IL-8 release by these cells.	BzATP	35-40	C-X-C motif chemokine ligand 8	Homo sapiens	143-147